tiprankstipranks
Trending News
More News >
Actinogen Medical Limited (AU:ACW)
ASX:ACW
Australian Market

Actinogen Medical (ACW) Ratios

Compare
38 Followers

Actinogen Medical Ratios

AU:ACW's free cash flow for Q2 2026 was AU$0.00. For the 2026 fiscal year, AU:ACW's free cash flow was decreased by AU$ and operating cash flow was AU$0.00. See a summary of the company’s cash flow.
Ratios
TTM
Jun 25Jun 24Jun 23Jun 22
Liquidity Ratios
Current Ratio
4.19 3.76 13.91 7.04 13.80
Quick Ratio
4.19 3.76 13.91 7.04 13.80
Cash Ratio
3.12 2.77 6.96 4.70 11.06
Solvency Ratio
-7.85 -2.34 -7.82 -5.74 -5.81
Operating Cash Flow Ratio
-7.85 -1.27 -12.49 -4.83 -6.43
Short-Term Operating Cash Flow Coverage
-201.46 -2.51 -279.38 -100.06 -121.49
Net Current Asset Value
AU$ 6.53MAU$ 16.28MAU$ 17.26MAU$ 10.89MAU$ 18.85M
Leverage Ratios
Debt-to-Assets Ratio
0.03 0.13 0.01 <0.01 <0.01
Debt-to-Equity Ratio
0.04 0.18 0.02 <0.01 <0.01
Debt-to-Capital Ratio
0.04 0.15 0.02 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
0.02 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.27 1.34 1.08 1.13 1.07
Debt Service Coverage Ratio
-68.58 -3.12 -34.22 -99.78 -93.77
Interest Coverage Ratio
-110.71 -305.42 -528.53 -956.27 -712.89
Debt to Market Cap
<0.01 0.04 <0.01 <0.01 <0.01
Interest Debt Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
0.31 0.88 0.71 0.55 1.27
Profitability Margins
Gross Profit Margin
96.16%100.00%100.00%91.70%88.99%
EBIT Margin
-369.31%-279.70%-133.47%-319.64%-360.40%
EBITDA Margin
-362.21%-273.48%-129.28%-311.34%-349.40%
Operating Profit Margin
-365.31%-272.01%-129.28%-324.74%-361.90%
Pretax Profit Margin
-360.40%-268.37%-231.34%-319.98%-360.91%
Net Profit Margin
-326.26%-268.37%-131.34%-219.98%-260.91%
Continuous Operations Profit Margin
-326.26%-168.37%-131.34%-219.98%-260.91%
Net Income Per EBT
90.53%100.00%56.77%68.75%72.29%
EBT Per EBIT
98.65%98.66%178.95%98.53%99.73%
Return on Assets (ROA)
-168.94%-60.18%-61.21%-70.70%-40.75%
Return on Equity (ROE)
-134.14%-80.35%-66.23%-80.20%-43.69%
Return on Capital Employed (ROCE)
-235.63%-80.62%-64.34%-118.39%-60.35%
Return on Invested Capital (ROIC)
-211.28%-43.37%-36.31%-80.35%-43.32%
Return on Tangible Assets
-199.52%-64.90%-67.88%-83.99%-46.14%
Earnings Yield
-15.61%-21.50%-9.23%-15.13%-11.22%
Efficiency Ratios
Receivables Turnover
2.52 0.95 1.07 1.26 0.92
Payables Turnover
0.24 0.00 0.70 0.37 0.45
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
25.13 20.33 29.08 43.37 21.54
Asset Turnover
0.52 0.22 0.47 0.32 0.16
Working Capital Turnover Ratio
0.47 0.32 0.70 0.33 0.22
Cash Conversion Cycle
-1.35K 385.41 -180.57 -701.18 -423.45
Days of Sales Outstanding
144.74 385.41 342.41 290.02 395.28
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
1.50K 0.00 522.97 991.20 818.73
Operating Cycle
144.74 385.41 342.41 290.02 395.28
Cash Flow Ratios
Operating Cash Flow Per Share
>-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Free Cash Flow Per Share
>-0.01 >-0.01 >-0.01 >-0.01 >-0.01
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.00 1.01 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
-427.74 -198.73 -2.08K -237.66 -3.24K
Capital Expenditure Coverage Ratio
-427.74 -198.73 -2.08K -237.66 -3.24K
Operating Cash Flow Coverage Ratio
-44.81 -2.31 -53.13 -100.06 -57.59
Operating Cash Flow to Sales Ratio
-2.99 -1.38 -1.71 -1.78 -2.61
Free Cash Flow Yield
-12.78%-11.08%-12.00%-12.29%-11.24%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-6.41 -4.65 -10.83 -6.61 -8.92
Price-to-Sales (P/S) Ratio
23.45 12.48 14.23 14.54 23.26
Price-to-Book (P/B) Ratio
13.71 3.74 7.18 5.30 3.90
Price-to-Free Cash Flow (P/FCF) Ratio
-7.82 -9.03 -8.33 -8.14 -8.89
Price-to-Operating Cash Flow Ratio
-6.99 -9.07 -8.34 -8.17 -8.90
Price-to-Earnings Growth (PEG) Ratio
-0.07 0.25 -2.06 -0.88 -0.09
Price-to-Fair Value
13.71 3.74 7.18 5.30 3.90
Enterprise Value Multiple
-6.16 -3.68 -10.30 -4.12 -5.38
Enterprise Value
122.56M 55.30M 132.20M 62.70M 68.48M
EV to EBITDA
-6.16 -3.68 -10.30 -4.12 -5.38
EV to Sales
22.33 10.07 13.31 12.83 18.81
EV to Free Cash Flow
-7.45 -7.28 -7.80 -7.18 -7.19
EV to Operating Cash Flow
-7.47 -7.32 -7.80 -7.21 -7.19
Tangible Book Value Per Share
<0.01 <0.01 <0.01 <0.01 0.01
Shareholders’ Equity Per Share
<0.01 <0.01 <0.01 <0.01 0.01
Tax and Other Ratios
Effective Tax Rate
0.09 0.37 0.43 0.31 0.28
Revenue Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Net Income Per Share
>-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Tax Burden
0.91 1.00 0.57 0.69 0.72
Interest Burden
0.98 0.96 1.73 1.00 1.00
Research & Development to Revenue
3.03 2.24 1.56 1.82 2.26
SG&A to Revenue
0.19 0.37 0.17 0.37 0.37
Stock-Based Compensation to Revenue
0.17 0.00 0.00 0.31 0.35
Income Quality
0.92 0.00 1.30 0.81 1.00
Currency in AUD